These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2146853)

  • 41. A comparison of the effects of Buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosis.
    Dlugi AM; Rufo S; D'Amico JF; Seibel MM
    Fertil Steril; 1988 May; 49(5):913-6. PubMed ID: 3129319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppression of gonadotrophin secretion does not reverse premature ovarian failure.
    Ledger WL; Thomas EJ; Browning D; Lenton EA; Cooke ID
    Br J Obstet Gynaecol; 1989 Feb; 96(2):196-9. PubMed ID: 2522795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized, comparative trial of triptorelin depot (D-Trp6-LHRH) and danazol in the treatment of endometriosis.
    Cirkel U; Ochs H; Schneider HP
    Eur J Obstet Gynecol Reprod Biol; 1995 Mar; 59(1):61-9. PubMed ID: 7781864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hormonal, metabolic and clinical effects of danazol in the treatment of endometriosis.
    Rannevik G
    Postgrad Med J; 1979; 55 Suppl 5():14-20. PubMed ID: 537948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased sensitivity to insulin during treatment with danazol in women with endometriosis.
    Matalliotakis I; Panidis D; Vlassis G; Neonaki M; Koumantakis E
    Clin Exp Obstet Gynecol; 1997; 24(3):160-2. PubMed ID: 9478307
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of intranasal buserelin acetate in the treatment of endometriosis: a review of six clinical trials and comparison with danazol.
    Trabant H; Widdra W; de Looze S
    Prog Clin Biol Res; 1990; 323():357-82. PubMed ID: 2106146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hormone treatment related bone mineral content changes in Japanese women with endometriosis.
    Fukushima M; Shindo M; Sato K
    Asia Oceania J Obstet Gynaecol; 1993 Sep; 19(3):299-307. PubMed ID: 8250765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of danazol in the treatment of severe endometriosis.
    Rönnberg L; Ylöstalo P; Järvinen PA
    Postgrad Med J; 1979; 55 Suppl 5():21-6. PubMed ID: 537949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized, prospective comparison of endocrine changes induced with intranasal leuprolide or danazol for treatment of endometriosis.
    Tummon IS; Pepping ME; Binor Z; Radwanska E; Dmowski WP
    Fertil Steril; 1989 Mar; 51(3):390-4. PubMed ID: 2522062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Experience with a depot GnRH-agonist (Zoladex) in the treatment of genital endometriosis.
    Mettler L; Steinmüller H; Schachner-Wünschmann E
    Hum Reprod; 1991 May; 6(5):694-8. PubMed ID: 1834693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GnRH agonists-antagonists--clinical applications.
    Shaw RW
    Eur J Obstet Gynecol Reprod Biol; 1988 Jun; 28(2):109-16. PubMed ID: 2969835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The hypothalamic-pituitary-ovarian axis in patients with endometriosis is suppressed by leuprolide acetate but not by danazol.
    Sakata M; Ohtsuka S; Kurachi H; Miyake A; Terakawa N; Tanizawa O
    Fertil Steril; 1994 Mar; 61(3):432-7. PubMed ID: 8137962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Goserelin (Zoladex) depot in the treatment of endometriosis. Zoladex Endometriosis Study Group.
    Reichel RP; Schweppe KW
    Fertil Steril; 1992 Jun; 57(6):1197-202. PubMed ID: 1534773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of danazol in the management of endometriosis.
    Young MD; Blackmore WP
    J Int Med Res; 1977; 5 Suppl 3():86-91. PubMed ID: 913886
    [No Abstract]   [Full Text] [Related]  

  • 55. Vaginal patterns during danazol and buserelin acetate therapy for endometriosis: structural and ultrastructural study.
    Fedele L; Marchini M; Bianchi S; Baglioni A; Zanotti F
    Fertil Steril; 1993 Jun; 59(6):1191-5. PubMed ID: 8495764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prolactin and pituitary gonadotropin values and responses to acute luteinizing hormone-releasing hormone (LHRH) challenge in patients having long-term treatment with a depot LHRH analogue.
    Mahler C; Verhelst J; Chaban M; Denis L
    Cancer; 1991 Feb; 67(3):557-9. PubMed ID: 1824680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects and safety of gonadotrophin-releasing hormone agonist combined with estradiol patch and oral medroxyprogesterone acetate on endometriosis].
    Wang YQ; Zhang SF; Chen X; Zhu J; Hua KQ; Hu WG
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):504-8. PubMed ID: 19957549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer.
    Ahmann FR; Citrin DL; deHaan HA; Guinan P; Jordan VC; Kreis W; Scott M; Trump DL
    J Clin Oncol; 1987 Jun; 5(6):912-7. PubMed ID: 2953870
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.
    Howell R; Edmonds DK; Dowsett M; Crook D; Lees B; Stevenson JC
    Fertil Steril; 1995 Sep; 64(3):474-81. PubMed ID: 7641897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Laparoscopic findings and hormonal patterns in the treatment of endometriosis by danazol.
    Tolino A; Romano L; Chiacchio G; Ronsini S; Montemagno U
    Acta Eur Fertil; 1987; 18(2):85-9. PubMed ID: 2957884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.